GDF15 and lung cancer: Moreover, when all patients with lung cancer were grouped according to TNM classification, the gradual increasement in serum MIC-1 levels was evident (P = 0.042), with higher levels in advanced patients compared with early-stage patients (Table 1), implying the positive correlation of MIC-1 with lung cancer progression.